NLRP3 and diabetes mellitus: Several reports suggest that deregulated activation of NLRP3 inflammasome is involved in arthritis (27), diabetes (28), and chronic diseases such as metabolic syndrome, atherosclerosis, and other age-related diseases (29), and that its altered activity might increase the susceptibility to psoriasis (30).